학술논문
[Gamma]-secretase heterogeneity in the Aph1 subunit: relevance for Alzheimer's disease
Document Type
Author abstract
Report
Report
Author
Serneels, Lutgarde; Van Biervliet, Jerome; Craessaerts, Katleen; Dejaegere, Tim; Horre, Katrien; Van Houtvin, Tine; Esselmann, Hermann; Paul, Sabine; Schafer, Martin K.; Berezovska, Oksana; Hyman, Bradley T.; Sprangers, Ben; Sciot, Raf; Moons, Lieve; Jucker, Mathias; Yang, Zhixiang; May, Patrick C.; Karran, Eric; Wiltfang, Jens; D'Hooge, Rudi; De Strooper, Bart
Source
Science. May 1, 2009, Vol. 324 Issue 5927, p639, 4 p.
Subject
Language
English
ISSN
0036-8075
Abstract
The [gamma]-secretase complex plays a role in Alzheimer's disease and cancer progression. The development of clinically useful inhibitors, however, is complicated by the role of the [gamma]-secretase complex in regulated intramembrane proteolysis of Notch and other essential proteins. Different [gamma]-secretase complexes containing different Presenilin or Aph1 protein subunits are present in various tissues. Here we show that these complexes have heterogeneous biochemical and physiological properties. Specific inactivation of the Aph1B [gamma]-secretase in a mouse Alzheimer's disease model red to improvements of Alzheimer's disease-relevant phenotypic features without any Notch-related side effects. The Aph1B complex contributes to total [gamma]-secretase activity in the human brain, and thus specific targeting of Aph1B-containing [gamma]-secretase complexes may help generate less toxic therapies for Alzheimer's disease.